ACCD Quote, Financials, Valuation and Earnings

HealthStream has a net margin of -115.42% compared to Accolade's net margin of 6.59%. Accolade's return on equity of -43.94% beat HealthStream's return on equity of 5.72%.

Accolade has a consensus price target of $7.03, signalling upside risk potential of 0.51%. On the other hand HealthStream has an analysts' consensus of $35.00 which suggests that it could grow by 9.72%. Given that HealthStream has higher upside potential than Accolade, analysts believe HealthStream is more attractive than Accolade.

Accolade has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison HealthStream has a beta of 0.374, suggesting its less volatile than the S&P 500 by 62.556%.

Accolade has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthStream offers a yield of 0.36% to investors and pays a quarterly dividend of $0.03 per share. Accolade pays -- of its earnings as a dividend. HealthStream pays out 17.01% of its earnings as a dividend. HealthStream's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Accolade quarterly revenues are $105.1M, which are larger than HealthStream quarterly revenues of $74.2M. Accolade's net income of -$121.3M is lower than HealthStream's net income of $4.9M. Notably, Accolade's price-to-earnings ratio is -- while HealthStream's PE ratio is 48.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Accolade is 1.23x versus 3.34x for HealthStream. Usually stocks with elevated PS ratios are considered overvalued.

Schrodinger has a net margin of -115.42% compared to Accolade's net margin of -45.54%. Accolade's return on equity of -43.94% beat Schrodinger's return on equity of -38.87%.

Accolade has a consensus price target of $7.03, signalling upside risk potential of 0.51%. On the other hand Schrodinger has an analysts' consensus of $30.80 which suggests that it could grow by 49.52%. Given that Schrodinger has higher upside potential than Accolade, analysts believe Schrodinger is more attractive than Accolade.

Accolade has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Schrodinger has a beta of 1.624, suggesting its more volatile than the S&P 500 by 62.426%.

Accolade has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Schrodinger offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Accolade pays -- of its earnings as a dividend. Schrodinger pays out -- of its earnings as a dividend.

Accolade quarterly revenues are $105.1M, which are larger than Schrodinger quarterly revenues of $88.3M. Accolade's net income of -$121.3M is lower than Schrodinger's net income of -$40.2M. Notably, Accolade's price-to-earnings ratio is -- while Schrodinger's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Accolade is 1.23x versus 7.21x for Schrodinger. Usually stocks with elevated PS ratios are considered overvalued.

Simulations Plus has a net margin of -115.42% compared to Accolade's net margin of 1.09%. Accolade's return on equity of -43.94% beat Simulations Plus's return on equity of 4.58%.

Accolade has a consensus price target of $7.03, signalling upside risk potential of 0.51%. On the other hand Simulations Plus has an analysts' consensus of $49.40 which suggests that it could grow by 105.83%. Given that Simulations Plus has higher upside potential than Accolade, analysts believe Simulations Plus is more attractive than Accolade.

Accolade has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Simulations Plus has a beta of 0.894, suggesting its less volatile than the S&P 500 by 10.602%.

Accolade has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus offers a yield of 1% to investors and pays a quarterly dividend of $0.06 per share. Accolade pays -- of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Accolade quarterly revenues are $105.1M, which are larger than Simulations Plus quarterly revenues of $18.9M. Accolade's net income of -$121.3M is lower than Simulations Plus's net income of $206K. Notably, Accolade's price-to-earnings ratio is -- while Simulations Plus's PE ratio is 60.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Accolade is 1.23x versus 6.55x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.